Integrating Evidence-based Approaches to Prevent Child Maltreatment in Kyrgyzstan (NCT07712822) | Clinical Trial Compass
RecruitingNot Applicable
Integrating Evidence-based Approaches to Prevent Child Maltreatment in Kyrgyzstan
Kyrgyzstan396 participantsStarted 2026-09-01
Plain-language summary
The goal of this clinical trial is to learn if a family-based prevention program works to prevent child maltreatment risk and other adverse childhood experiences (ACEs) among families in Kyrgyzstan. It will also learn about the safety, feasibility, and acceptability of the program. The main questions it aims to answer are: (1) Does the integrated family and economic empowerment program improve children's self-regulation, behavioral adjustment, and school adaptation? (2) Is the program feasible and acceptable for families and schools in Kyrgyzstan?
Researchers will compare the integrated prevention program to bolstered standard school services to see if the program improves child and family outcomes. Participants will: (a) Be randomly assigned to either the prevention program or bolstered standard school services; (b) Attend weekly group sessions for 16 weeks (if assigned to the prevention program); (c) Complete surveys at baseline, immediately after the 16-week program, and at the end of the school year; and (d) Provide information about child behavior, (co)parenting, family relationships, and financial well-being.
Results from this pilot study will inform a future larger trial.
Who can participate
Age range
6 Years – 74 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Two adult caregivers (≥18 years old) who identify as co-parents or primary caregivers of a target child
* Target child aged 6-9 years enrolled in one of the participating schools in Bishkek, Kyrgyzstan
* Both caregivers identify each other as family members responsible for the care of the child (e.g., parents, grandparents, or other adult caregivers)
* Both caregivers report feeling safe participating together in a family-based program
* Both caregivers are fluent in either Russian or Kyrgyz
* Both caregivers are able and willing to provide informed consent
* Child is able to provide assent and participate in age-appropriate assessments.
* Family is willing to participate in study procedures, including random assignment and completion of assessments at baseline, post-intervention (16 weeks), and end-of-school-year follow-up.
Exclusion Criteria:
* Report of severe physical or sexual intimate partner violence between caregivers within the past 12 months, as assessed during screening
* Either caregiver is unable to provide informed consent
* Either caregiver has a cognitive impairment or a severe mental health condition that would preclude participation in group sessions
* Family plans to relocate outside the study area during the intervention period
* Child has a severe developmental or medical condition that would prevent participation in assessments
* Inability to communicate in Russian or Kyrgyz.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Strengths and Difficulties Questionnaire (SDQ) Parent Report
Timeframe: Up to 1.5 years after baseline
2
Strengths and Difficulties Questionnaire (SDQ) Self-Report (Youth version)
Timeframe: Baseline through 1.5 years after baseline
3
Strengths and Difficulties Questionnaire (SDQ) Teacher Report